Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants

Over the past two years, several variants of SARS-CoV-2 have emerged and spread all over the world. However, infectivity, clinical severity, re-infection, virulence, transmissibility, vaccine responses and escape, and epidemiological aspects have differed between SARS-CoV-2 variants. Currently, very...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Océane Delandre, Mathieu Gendrot, Priscilla Jardot, Marion Le Bideau, Manon Boxberger, Céline Boschi, Isabelle Fonta, Joel Mosnier, Sébastien Hutter, Anthony Levasseur, Bernard La Scola, Bruno Pradines
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2022-04-01
Serija:Pharmaceuticals
Teme:
COVID-19
SARS-CoV-2
in vitro
ivermectin
remdesivir
chloroquine
Online pristup:https://www.mdpi.com/1424-8247/15/4/445
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items